fbpx
QQQ
+ 1.73
340.90
+ 0.5%
DIA
+ 5.77
327.19
+ 1.73%
SPY
+ 5.82
409.10
+ 1.4%
TLT
-2.44
148.17
-1.67%
GLD
+ 2.00
162.93
+ 1.21%

Analyzing The Price Action In Oncternal Therapeutics Stock Today

March 17, 2021 10:55 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The Price And Volume Action In Oncternal Therapeutics's Stock Today

Oncternal Therapeutics's (NASDAQ:ONCT) stock has been rising Wednesday, up 7.54% to a price of $9.06. Wednesday the stock has been traded at a volume of 949.72 thousand, about 65.86% of its recent 30-day volume average of 1.44 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Oncternal Therapeutics shares are trading higher. Not seeing any company-specific news to justify the price action.

Perspective On Recent Price Action

The moving average price of the stock over the past 50 days was $6.25 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $8.95 and as low as $1.49.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Movers Trading Ideas

Related Articles

Analyzing The Price Action In Oncternal Therapeutics Stock Today

Oncternal Therapeutics's Stock Price And Volume Action Oncternal Therapeutics's (NASDAQ:ONCT) stock has been rising Wednesday, up 4.61% to a price of $9.13. The stock's volume is currently 126.68 thousand, which is roughly 8.74% of its recent 30-day volume average of 1.45 million. read more

Oncternal Shares Jump After Encouraging Early Action In Soft-Tissue Sarcoma Trial With TK216

20 Stocks Moving in Thursday's Pre-Market Session

Gainers PDS Biotechnology Corporation (NASDAQ: PDSB) rose 18% to $6.77 in pre-market trading as traders circulated abstract from American Society Of Clinical Oncology website. read more

55 Biggest Movers From Yesterday

Gainers read more